Euronet Worldwide
EEFT
62.52
-1.02
-1.61%
Euronet Worldwide
US · EEFT
#2655 by market cap
Listed 1970
62.52
-1.02
-1.61%
Live - 5344 symbols - heartbeat 109s ago
· 2026-10-08 08:13
Pre-market
62.03
-0.78%
After-hours
62.52
0.00%
- Market cap
- 2.34B
- P/E (TTM)i
- 9.92
- P/Bi
- 1.90
- EPSi
- 6.84
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on EEFT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.76, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.38% YoY
Margins
- Gross margin
- 41.32%
- Operating margin
- 12.49%
- Net margin
- 7.29%
Key ratios & quality
- Enterprise valuei
- 2.72B
- PEG ratioi
- 0.97
- Altman Z-Scorei
- 1.76
PEG uses trailing P/E against the 3-year net income growth rate (10.24%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.54B | 2.75B | 2.48B | 3.00B | 3.36B | 3.69B | 3.99B | 4.24B |
| Gross profit | 1.05B | 1.19B | 906.00M | 1.10B | 1.34B | 1.47B | 1.60B | 1.75B |
| Selling & admin expenses | 577.24M | 606.69M | 625.76M | 736.90M | 819.30M | 899.70M | 965.50M | 1.09B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 364.96M | 475.19M | 153.22M | 222.60M | 385.40M | 432.60M | 503.20M | 530.00M |
| Pretax profit | 294.92M | 433.81M | 8.17M | 135.60M | 322.60M | 400.40M | 448.90M | 448.20M |
| Tax | 62.79M | 87.11M | 11.48M | 65.10M | 91.90M | 120.90M | 142.60M | 135.20M |
| Net profit | 232.13M | 346.70M | -3.30M | 70.50M | 230.70M | 279.50M | 306.30M | 313.00M |
| Basic EPS | 5 | 7 | 0 | 1 | 5 | 6 | 7 | 7 |
| Diluted EPS | 4.28 | 6.34 | -0.06 | 1.32 | 4.41 | 5.50 | 6.45 | 6.84 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 915.50M | 1.07B | 1.15B | 1.11B | 1.01B | 1.11B |
| Gross profit | 354.50M | 453.70M | 501.80M | 443.60M | 394.40M | 468.80M |
| Selling & admin expenses | 247.10M | 261.30M | 272.00M | 304.70M | 282.50M | 291.70M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 75.20M | 158.60M | 195.00M | 101.20M | 72.00M | 137.10M |
| Pretax profit | 45.50M | 131.30M | 180.20M | 91.20M | 66.30M | 124.30M |
| Tax | 7.10M | 33.60M | 55.10M | 39.40M | 29.00M | 46.70M |
| Net profit | 38.40M | 97.70M | 125.10M | 51.80M | 37.30M | 77.60M |
| Basic EPS | 1 | 2 | 3 | 1 | 1 | 2 |
| Diluted EPS | 0.85 | 2.27 | 2.75 | 1.08 | 0.83 | 1.71 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.09B | 2.92B | 3.37B | 3.31B | 3.73B | 4.16B | 4.04B | 4.27B |
| Cash & ST investments | 780.41M | 1.45B | 1.83B | 1.80B | 1.65B | 1.78B | 1.92B | 1.69B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 3.32B | 4.66B | 4.93B | 4.74B | 5.40B | 5.89B | 5.83B | 6.49B |
| Total current liabilities | 1.38B | 1.63B | 1.86B | 1.85B | 2.35B | 2.70B | 3.23B | 3.85B |
| Short-term debt | 43.48M | 139.36M | 59.64M | 57.10M | 53.30M | 202.20M | 862.30M | 1.04B |
| Long-term debt | 589.78M | 1.09B | 1.44B | 1.42B | 1.61B | 1.72B | 1.13B | 1.04B |
| Total liabilities | 2,088,313,000.00 | 3,078,324,000.00 | 3,480,808,000.00 | 3,488,752,000.00 | 4,159,200,000.00 | 4,644,700,000.00 | 4,605,300,000.00 | 5,166,200,000.00 |
| Total equity | 1.23B | 1.58B | 1.45B | 1.26B | 1.24B | 1.25B | 1.23B | 1.32B |
| Retained earnings | 669.81M | 1.02B | 1.01B | 1.08B | 1.35B | 1.63B | 1.93B | 2.24B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.17B | 4.54B | 4.24B | 4.27B | 4.16B | 4.33B |
| Cash & ST investments | 2.09B | 2.27B | 2.02B | 1.69B | 2.10B | 2.18B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 6.05B | 6.55B | 6.28B | 6.49B | 6.33B | 6.49B |
| Total current liabilities | 2.61B | 3.94B | 3.67B | 3.85B | 3.26B | 3.16B |
| Short-term debt | 346.20M | 1.49B | 1.29B | 1.04B | 1.03B | 882.90M |
| Long-term debt | 1.91B | 1.00B | 1.07B | 1.04B | 1.58B | 1.83B |
| Total liabilities | 4,751,800,000.00 | 5,191,500,000.00 | 4,996,800,000.00 | 5,166,200,000.00 | 5,105,100,000.00 | 5,247,800,000.00 |
| Total equity | 1.30B | 1.36B | 1.28B | 1.32B | 1.23B | 1.25B |
| Retained earnings | 1.97B | 2.07B | 2.19B | 2.24B | 2.28B | 2.36B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 397.23M | 504.49M | 253.51M | 406.30M | 748.30M | 643.10M | 732.80M | 559.80M |
| Depreciation & amortization | 106.02M | 111.74M | 127.02M | 135.80M | 135.90M | 132.90M | 131.80M | 138.50M |
| Free cash flow | 284.75M | 373.20M | 155.88M | 314.10M | 644.00M | 548.70M | 615.60M | 434.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -159.25M | -59.48M | -223.42M | -219.10M | -166.90M | -370.60M | -251.40M | -658.70M |
| Ending cash balance | 1.13B | 1.82B | 2.10B | 2.09B | 1.99B | 2.25B | 2.49B | 2.36B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.70M | 182.90M | 197.30M | 177.90M | -122.00M | 148.00M |
| Depreciation & amortization | 32.20M | 33.80M | 34.80M | 37.70M | 39.90M | 40.00M |
| Free cash flow | -21.70M | 148.50M | 161.20M | 146.30M | -150.50M | 111.90M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -61.50M | -245.60M | -128.80M | -222.80M | -102.40M | -49.90M |
| Ending cash balance | 2.69B | 2.92B | 2.69B | 2.36B | 2.61B | 2.74B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.16 | 24.66 | -0.22 | 5.24 | 18.48 | 22.43 | 24.69 | 24.41 |
| ROA %i | 7.21 | 8.69 | -0.07 | 1.46 | 4.55 | 4.95 | 5.22 | 5.02 |
| ROIC %i | 14.80 | 15.19 | 0.74 | 3.33 | 8.76 | 9.82 | 10.48 | 10.37 |
| 5-year avg ROE %i | 16.38 | 18.34 | 15.76 | 12.76 | 13.46 | 14.12 | 14.12 | 19.05 |
| EBIT margin %i | 13.11 | 17.09 | 1.80 | 5.80 | 10.72 | 12.36 | 13.27 | 12.55 |
| FCF / sales %i | 11.23 | 13.57 | 6.28 | 10.49 | 19.17 | 14.88 | 15.43 | 10.23 |
| Current ratioi | 1.51 | 1.79 | 1.81 | 1.79 | 1.58 | 1.54 | 1.25 | 1.11 |
| Quick ratioi | 0.71 | 1.01 | 1.05 | 1.08 | 0.81 | 0.80 | 0.68 | 0.53 |
| Debt / assetsi | 19.07 | 31.61 | 32.55 | 33.48 | 32.67 | 34.16 | 35.72 | 33.56 |
| LT debt / equityi | 47.85 | 84.40 | 106.81 | 121.98 | 137.54 | 144.91 | 99.44 | 87.05 |
| Interest coveragei | 8.85 | 12.97 | 1.22 | 4.55 | 9.58 | 8.20 | 6.58 | 6.30 |
| Revenue CAGR (3Y) %i | 12.70 | 11.98 | 3.30 | 5.70 | 6.89 | 14.10 | 10.03 | 8.11 |
| Net income CAGR (3Y) %i | 33.07 | 25.74 | -- | -32.79 | -12.66 | -- | 62.97 | 10.24 |
| FCF CAGR (3Y) %i | 26.57 | 7.06 | -6.23 | 3.32 | 19.94 | 52.12 | 25.14 | -12.31 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 25.00 | 25.94 | 23.10 | 24.41 | 24.55 | 22.34 |
| ROA %i | 5.42 | 5.27 | 4.83 | 5.02 | 4.98 | 4.42 |
| ROIC %i | 10.36 | 10.11 | 9.36 | 10.37 | 9.16 | 8.03 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.27 | 13.40 | 12.53 | 12.55 | 12.63 | 12.20 |
| FCF / sales %i | 14.52 | 14.20 | 7.99 | 10.23 | 7.04 | 6.15 |
| Current ratioi | 1.60 | 1.15 | 1.15 | 1.11 | 1.28 | 1.37 |
| Quick ratioi | 0.93 | 0.66 | 0.63 | 0.53 | 0.74 | 0.81 |
| Debt / assetsi | 38.82 | 39.56 | 39.18 | 33.56 | 42.71 | 43.23 |
| LT debt / equityi | 153.88 | 81.61 | 92.74 | 87.05 | 138.54 | 156.43 |
| Interest coveragei | 6.32 | 5.95 | 5.74 | 6.30 | 6.92 | 7.45 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Cross-Border Payments is the largest reported line at 39.66% of revenue, across 4 reported segments.
- No single line clears half of revenue; Payments Infrastructure is next at 34.02%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Cross-Border Payments39.66%
Payments Infrastructure34.02%
epay26.52%
Quote time 2026-10-08 08:13:41 · For reference only, not investment advice and not tailored to your situation.